Product Images Sildenafil Citrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Sildenafil Citrate NDC 50436-0005 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - lbl504360005

Label Image - lbl504360005

This is a prescription drug with the National Drug Code (NDC) 50436-0005-1. It contains Sildenafil of 20mg strength. Rest of the text is unclear.*

Graph - sildenafil tablets usp 20mg figure 06

Graph - sildenafil tablets usp 20mg figure 06

Graph - sildenafil tablets usp 20mg figure 07

Graph - sildenafil tablets usp 20mg figure 07

This text appears to be a chart or table related to drug interactions and dosages. It provides recommendations for nodose adjustment and fold change in interacting drugs and mentions the AUC and Cmax levels for different medicines. There is also a reference to a study on exercise capacity and the combination of certain drugs.*

Graph - sildenafil tablets usp 20mg figure 08

Graph - sildenafil tablets usp 20mg figure 08

This text is a drug interaction chart showing how the drug Acenocoumarol interacts with other drugs such as aspirin, atorvastatin, and phenprocoumon. The chart shows how the fold change and 90% CI Recommendation affect INR AUC, INR Cmax, BT, AUC, and Cmax. The chart recommends no dose adjustment for most of the drugs, whereas co-administration of Saquinavir with Acenocoumarol is not recommended. There's also a footnote indicating that based on the effect of ritonavir on sildenafil PK, no dose adjustment is required.*

Graph - sildenafil tablets usp 20mg figure 09

Graph - sildenafil tablets usp 20mg figure 09

This text seems to be a table showing the change from baseline in meters for four different dosage groups of a medication (placebo, 20mg, 40mg and 80mg). The data is presented for weeks 4, 8, and 12 in a study. Therefore, this text is likely a summary of the results from a clinical trial investigating the effectiveness of sildenafil on a certain condition.*

Graph - sildenafil tablets usp 20mg figure 10

Graph - sildenafil tablets usp 20mg figure 10

This appears to be a medical document discussing the use of placebo and sildenafil for patients with idiopathic pulmonary arterial hypertension. It includes patient data such as age, gender, and baseline walk distance. The document also includes metrics such as mean pulmonary artery pressure and placebo-corrected change in 6-minute walk distance.*

Graph - sildenafil tablets usp 20mg figure 11

Graph - sildenafil tablets usp 20mg figure 11

Graph - sildenafil tablets usp 20mg figure 12

Graph - sildenafil tablets usp 20mg figure 12

Structure Formula - sildenafil tablets usp 20mg structure

Structure Formula - sildenafil tablets usp 20mg structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.